

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.45406524 |
| 2 | cytidine deamination (GO:0009972) | 5.02162224 |
| 3 | cytidine metabolic process (GO:0046087) | 5.02162224 |
| 4 | cytidine catabolic process (GO:0006216) | 5.02162224 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.81043583 |
| 6 | regulation of autophagic vacuole assembly (GO:2000785) | 4.24070114 |
| 7 | polyketide metabolic process (GO:0030638) | 4.10395143 |
| 8 | doxorubicin metabolic process (GO:0044598) | 4.10395143 |
| 9 | daunorubicin metabolic process (GO:0044597) | 4.10395143 |
| 10 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.06499470 |
| 11 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.82368759 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.81468922 |
| 13 | regulation of vacuole organization (GO:0044088) | 3.69041178 |
| 14 | skeletal muscle contraction (GO:0003009) | 3.60290357 |
| 15 | actin nucleation (GO:0045010) | 3.49485105 |
| 16 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.49119279 |
| 17 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.45998549 |
| 18 | respiratory chain complex IV assembly (GO:0008535) | 3.41259488 |
| 19 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.40439107 |
| 20 | negative T cell selection (GO:0043383) | 3.36411483 |
| 21 | negative regulation of granulocyte differentiation (GO:0030853) | 3.31471667 |
| 22 | protein complex biogenesis (GO:0070271) | 3.28033702 |
| 23 | cytochrome complex assembly (GO:0017004) | 3.27332817 |
| 24 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.26754861 |
| 25 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.25561237 |
| 26 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.25561237 |
| 27 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.24587473 |
| 28 | response to interferon-beta (GO:0035456) | 3.21851871 |
| 29 | skeletal muscle adaptation (GO:0043501) | 3.21051033 |
| 30 | negative regulation of cell killing (GO:0031342) | 3.18977476 |
| 31 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.18977476 |
| 32 | DNA deamination (GO:0045006) | 3.16886202 |
| 33 | cellular response to exogenous dsRNA (GO:0071360) | 3.12821751 |
| 34 | cellular response to type I interferon (GO:0071357) | 3.10150089 |
| 35 | type I interferon signaling pathway (GO:0060337) | 3.10150089 |
| 36 | response to type I interferon (GO:0034340) | 3.09877195 |
| 37 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.09408706 |
| 38 | endosome to melanosome transport (GO:0035646) | 3.09285976 |
| 39 | endosome to pigment granule transport (GO:0043485) | 3.09285976 |
| 40 | lipoxygenase pathway (GO:0019372) | 3.08045893 |
| 41 | positive regulation of B cell differentiation (GO:0045579) | 3.07933231 |
| 42 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.07823011 |
| 43 | respiratory electron transport chain (GO:0022904) | 3.05317962 |
| 44 | lymph node development (GO:0048535) | 3.04087424 |
| 45 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.03409191 |
| 46 | cellular response to interferon-beta (GO:0035458) | 3.02421196 |
| 47 | immunoglobulin mediated immune response (GO:0016064) | 3.00311295 |
| 48 | response to peptidoglycan (GO:0032494) | 2.98872392 |
| 49 | electron transport chain (GO:0022900) | 2.98316386 |
| 50 | regulation of regulatory T cell differentiation (GO:0045589) | 2.95614517 |
| 51 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.95506866 |
| 52 | striated muscle atrophy (GO:0014891) | 2.95389833 |
| 53 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.94766209 |
| 54 | muscle atrophy (GO:0014889) | 2.92218335 |
| 55 | negative thymic T cell selection (GO:0045060) | 2.90283750 |
| 56 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.89898664 |
| 57 | NADH dehydrogenase complex assembly (GO:0010257) | 2.89898664 |
| 58 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.89898664 |
| 59 | positive regulation of granulocyte differentiation (GO:0030854) | 2.84560945 |
| 60 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.83175426 |
| 61 | sulfate transmembrane transport (GO:1902358) | 2.82745812 |
| 62 | inositol phosphate catabolic process (GO:0071545) | 2.81873615 |
| 63 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.81592839 |
| 64 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.80190133 |
| 65 | regulation of antigen processing and presentation (GO:0002577) | 2.78684957 |
| 66 | positive T cell selection (GO:0043368) | 2.77725228 |
| 67 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.77201474 |
| 68 | phospholipid scrambling (GO:0017121) | 2.76684831 |
| 69 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 2.73729290 |
| 70 | platelet dense granule organization (GO:0060155) | 2.73709690 |
| 71 | valine metabolic process (GO:0006573) | 2.73462466 |
| 72 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.72118693 |
| 73 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.70293316 |
| 74 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.70291626 |
| 75 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.69967795 |
| 76 | ATP synthesis coupled proton transport (GO:0015986) | 2.69967795 |
| 77 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.69719272 |
| 78 | regulation of relaxation of muscle (GO:1901077) | 2.68756739 |
| 79 | purine-containing compound salvage (GO:0043101) | 2.68548961 |
| 80 | muscle filament sliding (GO:0030049) | 2.68446832 |
| 81 | actin-myosin filament sliding (GO:0033275) | 2.68446832 |
| 82 | negative regulation of T cell apoptotic process (GO:0070233) | 2.66852796 |
| 83 | oxidative phosphorylation (GO:0006119) | 2.65878041 |
| 84 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.65642788 |
| 85 | adenosine metabolic process (GO:0046085) | 2.65546905 |
| 86 | superoxide anion generation (GO:0042554) | 2.65359842 |
| 87 | positive thymic T cell selection (GO:0045059) | 2.64593166 |
| 88 | germinal center formation (GO:0002467) | 2.64182761 |
| 89 | definitive hemopoiesis (GO:0060216) | 2.61494533 |
| 90 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.60545084 |
| 91 | mature B cell differentiation involved in immune response (GO:0002313) | 2.59740546 |
| 92 | sequestering of actin monomers (GO:0042989) | 2.59531615 |
| 93 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.56906116 |
| 94 | regulation of skeletal muscle contraction (GO:0014819) | 2.56307083 |
| 95 | defense response to protozoan (GO:0042832) | 2.55621215 |
| 96 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.55044507 |
| 97 | detection of molecule of bacterial origin (GO:0032490) | 2.54054471 |
| 98 | mitochondrial calcium ion transport (GO:0006851) | 2.53416187 |
| 99 | Peyers patch development (GO:0048541) | 2.53005837 |
| 100 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.53005837 |
| 101 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.52142997 |
| 102 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.51692799 |
| 103 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.50584698 |
| 104 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.50036700 |
| 105 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.49873313 |
| 106 | aggressive behavior (GO:0002118) | 2.49856136 |
| 107 | sulfate transport (GO:0008272) | 2.49201345 |
| 108 | interferon-gamma production (GO:0032609) | 2.49109411 |
| 109 | regulation of gamma-delta T cell activation (GO:0046643) | 2.48781688 |
| 110 | positive regulation of antigen processing and presentation (GO:0002579) | 2.48591508 |
| 111 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.48230361 |
| 112 | regulation of sequestering of triglyceride (GO:0010889) | 2.47935411 |
| 113 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.46514854 |
| 114 | regulation of B cell differentiation (GO:0045577) | 2.45046777 |
| 115 | energy homeostasis (GO:0097009) | 2.44801898 |
| 116 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.44712561 |
| 117 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.44394968 |
| 118 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.43870930 |
| 119 | deoxyribonucleotide catabolic process (GO:0009264) | 2.43690293 |
| 120 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.43243521 |
| 121 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.43243521 |
| 122 | NAD biosynthetic process (GO:0009435) | 2.43082821 |
| 123 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.42736100 |
| 124 | deoxyribose phosphate catabolic process (GO:0046386) | 2.42556187 |
| 125 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.42287098 |
| 126 | ubiquinone biosynthetic process (GO:0006744) | 2.41262337 |
| 127 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.41256563 |
| 128 | mature B cell differentiation (GO:0002335) | 2.40392376 |
| 129 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.40275963 |
| 130 | inositol phosphate dephosphorylation (GO:0046855) | 2.40275963 |
| 131 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.38436317 |
| 132 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.38246439 |
| 133 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.38246439 |
| 134 | megakaryocyte development (GO:0035855) | 2.38088216 |
| 135 | seminiferous tubule development (GO:0072520) | 2.37245474 |
| 136 | iron-sulfur cluster assembly (GO:0016226) | 2.37033809 |
| 137 | metallo-sulfur cluster assembly (GO:0031163) | 2.37033809 |
| 138 | neutrophil activation involved in immune response (GO:0002283) | 2.35714221 |
| 139 | oligosaccharide catabolic process (GO:0009313) | 2.35482909 |
| 140 | regulation of hypersensitivity (GO:0002883) | 2.34891273 |
| 141 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.34846421 |
| 142 | positive regulation of mast cell degranulation (GO:0043306) | 2.34846421 |
| 143 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.34614176 |
| 144 | purine nucleotide salvage (GO:0032261) | 2.34190705 |
| 145 | T cell receptor signaling pathway (GO:0050852) | 2.33621649 |
| 146 | positive regulation of protein sumoylation (GO:0033235) | 2.33202496 |
| 147 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.32217769 |
| 148 | response to interferon-alpha (GO:0035455) | 2.32208982 |
| 149 | nucleoside diphosphate catabolic process (GO:0009134) | 2.31912886 |
| 150 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.31253083 |
| 151 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.31045058 |
| 152 | protein-cofactor linkage (GO:0018065) | 2.30985306 |
| 153 | GPI anchor biosynthetic process (GO:0006506) | 2.29677386 |
| 154 | negative regulation of myotube differentiation (GO:0010832) | 2.28719940 |
| 155 | B cell mediated immunity (GO:0019724) | 2.28622868 |
| 156 | positive regulation of interleukin-4 production (GO:0032753) | 2.28369548 |
| 157 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.28313486 |
| 158 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.28139255 |
| 159 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.28005866 |
| 160 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.27360527 |
| 161 | T cell migration (GO:0072678) | 2.26342562 |
| 162 | mast cell activation (GO:0045576) | 2.26155667 |
| 163 | negative regulation of viral genome replication (GO:0045071) | 2.24932879 |
| 164 | regulation of cell communication by electrical coupling (GO:0010649) | 2.24176961 |
| 165 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.24009185 |
| 166 | regulation of vitamin metabolic process (GO:0030656) | 2.23496757 |
| 167 | response to protozoan (GO:0001562) | 2.22868729 |
| 168 | detection of other organism (GO:0098543) | 2.22630421 |
| 169 | dendritic cell chemotaxis (GO:0002407) | 2.21943935 |
| 170 | negative regulation of innate immune response (GO:0045824) | 2.21347416 |
| 171 | regulation of granulocyte differentiation (GO:0030852) | 2.20665477 |
| 172 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.20148849 |
| 173 | positive regulation of respiratory burst (GO:0060267) | 2.20055558 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.60734561 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.42428978 |
| 3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.05376641 |
| 4 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.47273585 |
| 5 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.41743643 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.32401560 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.31203875 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.14457332 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.10245014 |
| 10 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 3.01521991 |
| 11 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.88374841 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.84534644 |
| 13 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.74166424 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.70726853 |
| 15 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.57151431 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.54840102 |
| 17 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.43460481 |
| 18 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.42835047 |
| 19 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.39549918 |
| 20 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.31854702 |
| 21 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.27313175 |
| 22 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.26166197 |
| 23 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.22303421 |
| 24 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.17108676 |
| 25 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.14748496 |
| 26 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.13028203 |
| 27 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.11905492 |
| 28 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.06324129 |
| 29 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.02058169 |
| 30 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00289363 |
| 31 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.97816476 |
| 32 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.96387554 |
| 33 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.94610097 |
| 34 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.88455548 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.79786576 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.77606460 |
| 37 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.76864068 |
| 38 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.75396553 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.74209693 |
| 40 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.72053742 |
| 41 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.71930669 |
| 42 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.69272244 |
| 43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.68922690 |
| 44 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67592085 |
| 45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.67335450 |
| 46 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.67068280 |
| 47 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.66601855 |
| 48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.66413240 |
| 49 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.65457511 |
| 50 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.59458774 |
| 51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.58718690 |
| 52 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.58655633 |
| 53 | GATA3_26560356_Chip-Seq_TH2_Human | 1.56402886 |
| 54 | * MAF_26560356_Chip-Seq_TH1_Human | 1.53434644 |
| 55 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.53336649 |
| 56 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52674439 |
| 57 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.48972010 |
| 58 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.44663269 |
| 59 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.42558439 |
| 60 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.42501832 |
| 61 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.41341717 |
| 62 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.37940613 |
| 63 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.37101846 |
| 64 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.36731044 |
| 65 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.36664981 |
| 66 | VDR_22108803_ChIP-Seq_LS180_Human | 1.35028040 |
| 67 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.34954525 |
| 68 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.34636976 |
| 69 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.34604226 |
| 70 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.33715382 |
| 71 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.33425618 |
| 72 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.32790155 |
| 73 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31951279 |
| 74 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.30498753 |
| 75 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.29274499 |
| 76 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.27912082 |
| 77 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.27574271 |
| 78 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.26953010 |
| 79 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.26845632 |
| 80 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.25975060 |
| 81 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25224798 |
| 82 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.23215586 |
| 83 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.22566692 |
| 84 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22078034 |
| 85 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.20250264 |
| 86 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.20126794 |
| 87 | MAF_26560356_Chip-Seq_TH2_Human | 1.16762799 |
| 88 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.16086449 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16084335 |
| 90 | AR_20517297_ChIP-Seq_VCAP_Human | 1.15296263 |
| 91 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.15185284 |
| 92 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14957460 |
| 93 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14934480 |
| 94 | MYB_26560356_Chip-Seq_TH1_Human | 1.14682278 |
| 95 | MYB_26560356_Chip-Seq_TH2_Human | 1.12628042 |
| 96 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.12597157 |
| 97 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.12537840 |
| 98 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12045521 |
| 99 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.12031431 |
| 100 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11998816 |
| 101 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11921594 |
| 102 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11197430 |
| 103 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.09612204 |
| 104 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08776234 |
| 105 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.06942380 |
| 106 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06359412 |
| 107 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06100952 |
| 108 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05597921 |
| 109 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.05142949 |
| 110 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03923021 |
| 111 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.03391687 |
| 112 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.02482419 |
| 113 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.02208721 |
| 114 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01870656 |
| 115 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.01676373 |
| 116 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.01602875 |
| 117 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.00918736 |
| 118 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.00303381 |
| 119 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00194535 |
| 120 | MYC_22102868_ChIP-Seq_BL_Human | 0.99843229 |
| 121 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.99370690 |
| 122 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.99370690 |
| 123 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.99247383 |
| 124 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.99110369 |
| 125 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.98642147 |
| 126 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.98065335 |
| 127 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.95396987 |
| 128 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.95128273 |
| 129 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94755837 |
| 130 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.94499022 |
| 131 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.93860645 |
| 132 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.93462923 |
| 133 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.93086868 |
| 134 | P300_27268052_Chip-Seq_Bcells_Human | 0.92494255 |
| 135 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91455045 |
| 136 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.91004537 |
| 137 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.90866636 |
| 138 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.90311796 |
| 139 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.90096321 |
| 140 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88496467 |
| 141 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.88405497 |
| 142 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.88097743 |
| 143 | GATA3_26560356_Chip-Seq_TH1_Human | 0.87794081 |
| 144 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87589861 |
| 145 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85965250 |
| 146 | P68_20966046_ChIP-Seq_HELA_Human | 0.85807280 |
| 147 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85802708 |
| 148 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.85181722 |
| 149 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.84707720 |
| 150 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.84085446 |
| 151 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.83416290 |
| 152 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.83223391 |
| 153 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.83032589 |
| 154 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.82870175 |
| 155 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.82565280 |
| 156 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.82143187 |
| 157 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.81628549 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 3.38705584 |
| 2 | MP0003646_muscle_fatigue | 3.09110308 |
| 3 | MP0006292_abnormal_olfactory_placode | 2.99359298 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 2.83867038 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.83699826 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 2.66580004 |
| 7 | MP0003724_increased_susceptibility_to | 2.59937878 |
| 8 | MP0009785_altered_susceptibility_to | 2.41915317 |
| 9 | MP0005671_abnormal_response_to | 2.35876215 |
| 10 | MP0000685_abnormal_immune_system | 2.30562518 |
| 11 | MP0000013_abnormal_adipose_tissue | 2.29212261 |
| 12 | MP0003283_abnormal_digestive_organ | 2.18556186 |
| 13 | MP0001986_abnormal_taste_sensitivity | 2.10550841 |
| 14 | MP0000749_muscle_degeneration | 2.08882836 |
| 15 | MP0005025_abnormal_response_to | 1.97832441 |
| 16 | MP0005645_abnormal_hypothalamus_physiol | 1.97621111 |
| 17 | MP0004130_abnormal_muscle_cell | 1.88013706 |
| 18 | MP0001790_abnormal_immune_system | 1.87515906 |
| 19 | MP0005387_immune_system_phenotype | 1.87515906 |
| 20 | MP0006082_CNS_inflammation | 1.85417736 |
| 21 | MP0003436_decreased_susceptibility_to | 1.78048771 |
| 22 | MP0001800_abnormal_humoral_immune | 1.77724539 |
| 23 | MP0002419_abnormal_innate_immunity | 1.77697709 |
| 24 | MP0000372_irregular_coat_pigmentation | 1.77496574 |
| 25 | MP0005000_abnormal_immune_tolerance | 1.77196225 |
| 26 | MP0002723_abnormal_immune_serum | 1.68640364 |
| 27 | MP0002234_abnormal_pharynx_morphology | 1.66021005 |
| 28 | MP0003186_abnormal_redox_activity | 1.65732967 |
| 29 | MP0002420_abnormal_adaptive_immunity | 1.65606992 |
| 30 | MP0001819_abnormal_immune_cell | 1.65476316 |
| 31 | MP0002396_abnormal_hematopoietic_system | 1.64870349 |
| 32 | MP0002452_abnormal_antigen_presenting | 1.64019610 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.63044962 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.62676566 |
| 35 | MP0003183_abnormal_peptide_metabolism | 1.61613744 |
| 36 | MP0000751_myopathy | 1.55487283 |
| 37 | MP0003806_abnormal_nucleotide_metabolis | 1.52754444 |
| 38 | MP0004142_abnormal_muscle_tone | 1.47756157 |
| 39 | MP0010386_abnormal_urinary_bladder | 1.46875646 |
| 40 | MP0006036_abnormal_mitochondrial_physio | 1.44296854 |
| 41 | MP0005075_abnormal_melanosome_morpholog | 1.40942299 |
| 42 | MP0002102_abnormal_ear_morphology | 1.39735104 |
| 43 | MP0002822_catalepsy | 1.39348887 |
| 44 | MP0005084_abnormal_gallbladder_morpholo | 1.38808311 |
| 45 | MP0004036_abnormal_muscle_relaxation | 1.37786330 |
| 46 | MP0008875_abnormal_xenobiotic_pharmacok | 1.37041441 |
| 47 | MP0002398_abnormal_bone_marrow | 1.36338369 |
| 48 | MP0001905_abnormal_dopamine_level | 1.34758924 |
| 49 | MP0000343_altered_response_to | 1.34757958 |
| 50 | MP0005174_abnormal_tail_pigmentation | 1.32815683 |
| 51 | MP0000015_abnormal_ear_pigmentation | 1.27292551 |
| 52 | MP0003866_abnormal_defecation | 1.27043161 |
| 53 | MP0004145_abnormal_muscle_electrophysio | 1.25405617 |
| 54 | MP0002638_abnormal_pupillary_reflex | 1.24985514 |
| 55 | MP0003763_abnormal_thymus_physiology | 1.24487815 |
| 56 | MP0000716_abnormal_immune_system | 1.24219387 |
| 57 | MP0001853_heart_inflammation | 1.22225510 |
| 58 | MP0001188_hyperpigmentation | 1.21279477 |
| 59 | MP0002132_abnormal_respiratory_system | 1.21167081 |
| 60 | MP0005058_abnormal_lysosome_morphology | 1.20745243 |
| 61 | MP0008469_abnormal_protein_level | 1.20731373 |
| 62 | MP0004147_increased_porphyrin_level | 1.20347174 |
| 63 | MP0005167_abnormal_blood-brain_barrier | 1.20229066 |
| 64 | MP0005646_abnormal_pituitary_gland | 1.19822280 |
| 65 | MP0003045_fibrosis | 1.18390141 |
| 66 | MP0001845_abnormal_inflammatory_respons | 1.18254970 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 1.17759574 |
| 68 | MP0009764_decreased_sensitivity_to | 1.17681890 |
| 69 | MP0000678_abnormal_parathyroid_gland | 1.17541867 |
| 70 | MP0000689_abnormal_spleen_morphology | 1.15030454 |
| 71 | MP0010155_abnormal_intestine_physiology | 1.13815841 |
| 72 | MP0004808_abnormal_hematopoietic_stem | 1.12695637 |
| 73 | MP0002405_respiratory_system_inflammati | 1.12499636 |
| 74 | MP0005535_abnormal_body_temperature | 1.12389558 |
| 75 | MP0004215_abnormal_myocardial_fiber | 1.11982513 |
| 76 | MP0002138_abnormal_hepatobiliary_system | 1.11930805 |
| 77 | MP0002693_abnormal_pancreas_physiology | 1.11452587 |
| 78 | MP0003656_abnormal_erythrocyte_physiolo | 1.11289769 |
| 79 | MP0005666_abnormal_adipose_tissue | 1.10523745 |
| 80 | MP0002429_abnormal_blood_cell | 1.09371745 |
| 81 | MP0005379_endocrine/exocrine_gland_phen | 1.05589391 |
| 82 | MP0005334_abnormal_fat_pad | 1.05378636 |
| 83 | MP0004084_abnormal_cardiac_muscle | 1.05122010 |
| 84 | MP0002722_abnormal_immune_system | 1.05098572 |
| 85 | MP0002139_abnormal_hepatobiliary_system | 1.04585484 |
| 86 | MP0002106_abnormal_muscle_physiology | 1.03565915 |
| 87 | MP0008877_abnormal_DNA_methylation | 1.02407187 |
| 88 | MP0003828_pulmonary_edema | 1.02058786 |
| 89 | MP0009763_increased_sensitivity_to | 1.00005712 |
| 90 | MP0000569_abnormal_digit_pigmentation | 0.99957597 |
| 91 | MP0002928_abnormal_bile_duct | 0.98928733 |
| 92 | MP0000703_abnormal_thymus_morphology | 0.98590861 |
| 93 | MP0003279_aneurysm | 0.96011150 |
| 94 | MP0003172_abnormal_lysosome_physiology | 0.93990736 |
| 95 | MP0006072_abnormal_retinal_apoptosis | 0.93968471 |
| 96 | MP0005266_abnormal_metabolism | 0.92499110 |
| 97 | MP0002006_tumorigenesis | 0.91459639 |
| 98 | MP0002078_abnormal_glucose_homeostasis | 0.91194905 |
| 99 | MP0006276_abnormal_autonomic_nervous | 0.87953592 |
| 100 | MP0003252_abnormal_bile_duct | 0.87838866 |
| 101 | MP0003011_delayed_dark_adaptation | 0.87732969 |
| 102 | MP0002933_joint_inflammation | 0.87676032 |
| 103 | MP0001944_abnormal_pancreas_morphology | 0.86449701 |
| 104 | MP0003303_peritoneal_inflammation | 0.85875888 |
| 105 | MP0009115_abnormal_fat_cell | 0.84720393 |
| 106 | MP0000681_abnormal_thyroid_gland | 0.84217086 |
| 107 | MP0005375_adipose_tissue_phenotype | 0.83783772 |
| 108 | MP0002166_altered_tumor_susceptibility | 0.83741230 |
| 109 | MP0003195_calcinosis | 0.83451740 |
| 110 | MP0002876_abnormal_thyroid_physiology | 0.81992818 |
| 111 | MP0005636_abnormal_mineral_homeostasis | 0.81816502 |
| 112 | MP0000465_gastrointestinal_hemorrhage | 0.81271193 |
| 113 | MP0000003_abnormal_adipose_tissue | 0.81048837 |
| 114 | MP0004782_abnormal_surfactant_physiolog | 0.80721660 |
| 115 | MP0002998_abnormal_bone_remodeling | 0.80609256 |
| 116 | MP0002909_abnormal_adrenal_gland | 0.80427234 |
| 117 | MP0005397_hematopoietic_system_phenotyp | 0.79910279 |
| 118 | MP0001545_abnormal_hematopoietic_system | 0.79910279 |
| 119 | MP0003880_abnormal_central_pattern | 0.79505127 |
| 120 | MP0001533_abnormal_skeleton_physiology | 0.79443996 |
| 121 | MP0001765_abnormal_ion_homeostasis | 0.79426990 |
| 122 | MP0009278_abnormal_bone_marrow | 0.79391714 |
| 123 | MP0008004_abnormal_stomach_pH | 0.79358712 |
| 124 | MP0003787_abnormal_imprinting | 0.79337073 |
| 125 | MP0001764_abnormal_homeostasis | 0.79179344 |
| 126 | MP0005253_abnormal_eye_physiology | 0.79002488 |
| 127 | MP0005551_abnormal_eye_electrophysiolog | 0.78983433 |
| 128 | MP0006035_abnormal_mitochondrial_morpho | 0.78628770 |
| 129 | MP0008058_abnormal_DNA_repair | 0.78099639 |
| 130 | MP0008995_early_reproductive_senescence | 0.77339088 |
| 131 | MP0008775_abnormal_heart_ventricle | 0.76930007 |
| 132 | MP0001542_abnormal_bone_strength | 0.76273826 |
| 133 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.76131179 |
| 134 | MP0008872_abnormal_physiological_respon | 0.75852532 |
| 135 | MP0001968_abnormal_touch/_nociception | 0.75582030 |
| 136 | MP0005376_homeostasis/metabolism_phenot | 0.75515686 |
| 137 | MP0005360_urolithiasis | 0.74436586 |
| 138 | MP0002163_abnormal_gland_morphology | 0.73771734 |
| 139 | MP0002653_abnormal_ependyma_morphology | 0.73134093 |
| 140 | MP0010329_abnormal_lipoprotein_level | 0.73072612 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 3.89555038 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 3.83934882 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.63085893 |
| 4 | Progressive macrocephaly (HP:0004481) | 3.48513746 |
| 5 | Increased CSF lactate (HP:0002490) | 3.47153197 |
| 6 | Exercise-induced myalgia (HP:0003738) | 3.42129823 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 3.30460994 |
| 8 | Acute encephalopathy (HP:0006846) | 3.19206222 |
| 9 | Prolonged bleeding time (HP:0003010) | 3.18434421 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 3.13282719 |
| 11 | 3-Methylglutaconic aciduria (HP:0003535) | 3.05292922 |
| 12 | Exertional dyspnea (HP:0002875) | 2.97299400 |
| 13 | Petechiae (HP:0000967) | 2.95631366 |
| 14 | Stomatitis (HP:0010280) | 2.93885622 |
| 15 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.92692008 |
| 16 | Hypothermia (HP:0002045) | 2.90357655 |
| 17 | Aplastic anemia (HP:0001915) | 2.88609280 |
| 18 | Renal Fanconi syndrome (HP:0001994) | 2.83258281 |
| 19 | Increased muscle lipid content (HP:0009058) | 2.83044942 |
| 20 | Abnormality of B cell number (HP:0010975) | 2.80997776 |
| 21 | B lymphocytopenia (HP:0010976) | 2.75356877 |
| 22 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.73073731 |
| 23 | Asymmetric septal hypertrophy (HP:0001670) | 2.70358287 |
| 24 | Cerebral edema (HP:0002181) | 2.68919352 |
| 25 | Increased hepatocellular lipid droplets (HP:0006565) | 2.68175342 |
| 26 | Posterior subcapsular cataract (HP:0007787) | 2.68013695 |
| 27 | Increased intramyocellular lipid droplets (HP:0012240) | 2.67448068 |
| 28 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.66381584 |
| 29 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.64488693 |
| 30 | Severe visual impairment (HP:0001141) | 2.63908716 |
| 31 | Lipid accumulation in hepatocytes (HP:0006561) | 2.62073920 |
| 32 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.61546754 |
| 33 | Respiratory failure (HP:0002878) | 2.60994228 |
| 34 | Abnormality of the prostate (HP:0008775) | 2.60668092 |
| 35 | Generalized aminoaciduria (HP:0002909) | 2.55573259 |
| 36 | Myositis (HP:0100614) | 2.54705451 |
| 37 | Abnormality of glycolipid metabolism (HP:0010969) | 2.52227390 |
| 38 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.52227390 |
| 39 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.52227390 |
| 40 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.49242362 |
| 41 | Abnormality of alanine metabolism (HP:0010916) | 2.49242362 |
| 42 | Hyperalaninemia (HP:0003348) | 2.49242362 |
| 43 | Increased IgM level (HP:0003496) | 2.49229117 |
| 44 | Myoglobinuria (HP:0002913) | 2.49036221 |
| 45 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.48623705 |
| 46 | Lactic acidosis (HP:0003128) | 2.47892682 |
| 47 | Hepatic necrosis (HP:0002605) | 2.46271535 |
| 48 | Eczematoid dermatitis (HP:0000976) | 2.43555927 |
| 49 | IgM deficiency (HP:0002850) | 2.41108759 |
| 50 | Hypoproteinemia (HP:0003075) | 2.40138876 |
| 51 | Oligomenorrhea (HP:0000876) | 2.39521874 |
| 52 | IgG deficiency (HP:0004315) | 2.37338433 |
| 53 | T lymphocytopenia (HP:0005403) | 2.37186919 |
| 54 | Renal cortical cysts (HP:0000803) | 2.36716518 |
| 55 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.35987735 |
| 56 | Systemic lupus erythematosus (HP:0002725) | 2.35714270 |
| 57 | Chronic obstructive pulmonary disease (HP:0006510) | 2.32374598 |
| 58 | Obstructive lung disease (HP:0006536) | 2.32374598 |
| 59 | Autoimmune hemolytic anemia (HP:0001890) | 2.32028728 |
| 60 | Granulocytopenia (HP:0001913) | 2.31729124 |
| 61 | Panhypogammaglobulinemia (HP:0003139) | 2.31047428 |
| 62 | Dicarboxylic aciduria (HP:0003215) | 2.30529931 |
| 63 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.30529931 |
| 64 | Nemaline bodies (HP:0003798) | 2.30498519 |
| 65 | Albinism (HP:0001022) | 2.29811235 |
| 66 | Encephalitis (HP:0002383) | 2.29775104 |
| 67 | Acute hepatic failure (HP:0006554) | 2.27897072 |
| 68 | Abnormality of T cell number (HP:0011839) | 2.26347350 |
| 69 | Eosinophilia (HP:0001880) | 2.24865067 |
| 70 | Recurrent skin infections (HP:0001581) | 2.24629251 |
| 71 | Decreased circulating renin level (HP:0003351) | 2.24578603 |
| 72 | CNS demyelination (HP:0007305) | 2.23961545 |
| 73 | Recurrent cutaneous fungal infections (HP:0011370) | 2.23832582 |
| 74 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.23832582 |
| 75 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.22856955 |
| 76 | Combined immunodeficiency (HP:0005387) | 2.22466661 |
| 77 | Hypoglycemic coma (HP:0001325) | 2.21454873 |
| 78 | Late onset (HP:0003584) | 2.21016313 |
| 79 | Increased serum lactate (HP:0002151) | 2.18961110 |
| 80 | Recurrent fungal infections (HP:0002841) | 2.18938215 |
| 81 | Rhabdomyolysis (HP:0003201) | 2.17868380 |
| 82 | Optic disc pallor (HP:0000543) | 2.17716883 |
| 83 | Chronic diarrhea (HP:0002028) | 2.17220298 |
| 84 | Abnormality of macular pigmentation (HP:0008002) | 2.17087682 |
| 85 | Exercise intolerance (HP:0003546) | 2.16933889 |
| 86 | Abnormality of renal resorption (HP:0011038) | 2.16543541 |
| 87 | Ventricular tachycardia (HP:0004756) | 2.15894368 |
| 88 | Congenital stationary night blindness (HP:0007642) | 2.15521148 |
| 89 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.15471973 |
| 90 | Type 2 muscle fiber atrophy (HP:0003554) | 2.15428510 |
| 91 | Amyotrophic lateral sclerosis (HP:0007354) | 2.15317970 |
| 92 | Abnormality of T cells (HP:0002843) | 2.15279880 |
| 93 | Calf muscle hypertrophy (HP:0008981) | 2.15040853 |
| 94 | Exercise-induced muscle cramps (HP:0003710) | 2.14837182 |
| 95 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.13499436 |
| 96 | Subaortic stenosis (HP:0001682) | 2.11125243 |
| 97 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.11125243 |
| 98 | Meningitis (HP:0001287) | 2.11027855 |
| 99 | Gingivitis (HP:0000230) | 2.10294672 |
| 100 | Thyroiditis (HP:0100646) | 2.09456255 |
| 101 | Prostate neoplasm (HP:0100787) | 2.09064100 |
| 102 | Gastrointestinal infarctions (HP:0005244) | 2.08922549 |
| 103 | Dysostosis multiplex (HP:0000943) | 2.08389350 |
| 104 | Hypochromic microcytic anemia (HP:0004840) | 2.08081635 |
| 105 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.06187521 |
| 106 | Muscle fiber inclusion bodies (HP:0100299) | 2.05253299 |
| 107 | Reduced antithrombin III activity (HP:0001976) | 2.05072462 |
| 108 | Hepatocellular necrosis (HP:0001404) | 2.04400035 |
| 109 | Abnormality of eosinophils (HP:0001879) | 2.04388167 |
| 110 | Abnormality of T cell physiology (HP:0011840) | 2.03227782 |
| 111 | Breech presentation (HP:0001623) | 2.01614180 |
| 112 | Emotional lability (HP:0000712) | 2.00212392 |
| 113 | Toxemia of pregnancy (HP:0100603) | 1.99638375 |
| 114 | Flat capital femoral epiphysis (HP:0003370) | 1.99222408 |
| 115 | Abnormality of macrophages (HP:0004311) | 1.98973955 |
| 116 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.98684627 |
| 117 | Large for gestational age (HP:0001520) | 1.98211778 |
| 118 | Myotonia (HP:0002486) | 1.97406161 |
| 119 | Type I transferrin isoform profile (HP:0003642) | 1.96314402 |
| 120 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.94979728 |
| 121 | Progressive microcephaly (HP:0000253) | 1.94270287 |
| 122 | Muscle stiffness (HP:0003552) | 1.93719830 |
| 123 | Methylmalonic acidemia (HP:0002912) | 1.92906037 |
| 124 | Agammaglobulinemia (HP:0004432) | 1.92900526 |
| 125 | Distal arthrogryposis (HP:0005684) | 1.92813597 |
| 126 | Spastic paraparesis (HP:0002313) | 1.92117284 |
| 127 | Medial flaring of the eyebrow (HP:0010747) | 1.91675975 |
| 128 | Mitochondrial inheritance (HP:0001427) | 1.91337256 |
| 129 | Pancreatic cysts (HP:0001737) | 1.90224658 |
| 130 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.89654053 |
| 131 | Cerebral palsy (HP:0100021) | 1.89096507 |
| 132 | Severe combined immunodeficiency (HP:0004430) | 1.87092609 |
| 133 | Large eyes (HP:0001090) | 1.86790465 |
| 134 | Epistaxis (HP:0000421) | 1.86416849 |
| 135 | Progressive neurologic deterioration (HP:0002344) | 1.86399874 |
| 136 | Muscle fiber atrophy (HP:0100295) | 1.85462277 |
| 137 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.85440191 |
| 138 | Lipoatrophy (HP:0100578) | 1.85090113 |
| 139 | Abnormal hemoglobin (HP:0011902) | 1.84979932 |
| 140 | Inflammation of the large intestine (HP:0002037) | 1.83373900 |
| 141 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.83282319 |
| 142 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.83282319 |
| 143 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.82249773 |
| 144 | Orchitis (HP:0100796) | 1.80764985 |
| 145 | Attenuation of retinal blood vessels (HP:0007843) | 1.80137629 |
| 146 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.79955525 |
| 147 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.79955525 |
| 148 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.79955525 |
| 149 | Retrobulbar optic neuritis (HP:0100654) | 1.79604093 |
| 150 | Optic neuritis (HP:0100653) | 1.79604093 |
| 151 | Glycosuria (HP:0003076) | 1.79210200 |
| 152 | Abnormality of urine glucose concentration (HP:0011016) | 1.79210200 |
| 153 | Gastrointestinal inflammation (HP:0004386) | 1.78798891 |
| 154 | Dilated cardiomyopathy (HP:0001644) | 1.78143785 |
| 155 | Microcytic anemia (HP:0001935) | 1.78093815 |
| 156 | Metaphyseal dysplasia (HP:0100255) | 1.77444329 |
| 157 | Nonprogressive disorder (HP:0003680) | 1.77332191 |
| 158 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.77259372 |
| 159 | Abnormality of the renal cortex (HP:0011035) | 1.76897272 |
| 160 | Abnormality of iron homeostasis (HP:0011031) | 1.76329404 |
| 161 | Abnormal platelet function (HP:0011869) | 1.76001794 |
| 162 | Impaired platelet aggregation (HP:0003540) | 1.76001794 |
| 163 | Constricted visual fields (HP:0001133) | 1.74755733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 7.84015718 |
| 2 | INSRR | 3.05845381 |
| 3 | TESK2 | 2.90549594 |
| 4 | IRAK4 | 2.70212753 |
| 5 | MAPKAPK3 | 2.54087317 |
| 6 | FLT3 | 2.26017268 |
| 7 | PIK3CA | 2.20375624 |
| 8 | BLK | 2.17820046 |
| 9 | KIT | 2.13967304 |
| 10 | MAPK15 | 2.07598253 |
| 11 | IRAK3 | 2.07021611 |
| 12 | TGFBR2 | 1.95447015 |
| 13 | TNIK | 1.92201089 |
| 14 | ERBB3 | 1.89089949 |
| 15 | TESK1 | 1.82949998 |
| 16 | PIK3CG | 1.82411411 |
| 17 | IRAK1 | 1.80271386 |
| 18 | FRK | 1.78872623 |
| 19 | BTK | 1.72479430 |
| 20 | FES | 1.71280405 |
| 21 | NUAK1 | 1.69460768 |
| 22 | MAPK13 | 1.68984123 |
| 23 | CSNK1G3 | 1.62535483 |
| 24 | TEC | 1.61312901 |
| 25 | LIMK1 | 1.56974869 |
| 26 | MAP3K14 | 1.54156031 |
| 27 | EPHB2 | 1.52550060 |
| 28 | GRK7 | 1.50792994 |
| 29 | MST1R | 1.47071941 |
| 30 | TIE1 | 1.46691957 |
| 31 | TXK | 1.37449033 |
| 32 | JAK3 | 1.37207840 |
| 33 | SCYL2 | 1.36053387 |
| 34 | MAP4K2 | 1.35946092 |
| 35 | SIK3 | 1.33629963 |
| 36 | MAP4K1 | 1.33427190 |
| 37 | GRK6 | 1.32813678 |
| 38 | OBSCN | 1.31736619 |
| 39 | CSNK1G2 | 1.29196043 |
| 40 | ZAK | 1.29070964 |
| 41 | NME2 | 1.28877876 |
| 42 | MAP3K11 | 1.26516150 |
| 43 | IKBKE | 1.26360051 |
| 44 | TYK2 | 1.25532005 |
| 45 | ADRBK2 | 1.20836080 |
| 46 | VRK2 | 1.18014039 |
| 47 | BCKDK | 1.17871500 |
| 48 | ZAP70 | 1.15968871 |
| 49 | PHKG1 | 1.13303604 |
| 50 | PHKG2 | 1.13303604 |
| 51 | IRAK2 | 1.11173988 |
| 52 | TRPM7 | 1.10814588 |
| 53 | RIPK1 | 1.10589157 |
| 54 | RIPK4 | 1.09787109 |
| 55 | MUSK | 1.08986447 |
| 56 | TRIM28 | 1.08232804 |
| 57 | STK16 | 1.07777216 |
| 58 | PRPF4B | 1.01241629 |
| 59 | TBK1 | 1.00913729 |
| 60 | MST4 | 1.00380018 |
| 61 | CSNK1G1 | 0.99822248 |
| 62 | MYLK | 0.99678734 |
| 63 | PINK1 | 0.99470802 |
| 64 | PRKCQ | 0.97226726 |
| 65 | DAPK1 | 0.96748942 |
| 66 | NEK9 | 0.95327211 |
| 67 | CSF1R | 0.94380863 |
| 68 | SYK | 0.92676128 |
| 69 | MAP2K3 | 0.91851686 |
| 70 | TTN | 0.90898391 |
| 71 | CSNK1A1L | 0.88855801 |
| 72 | CDK19 | 0.88059871 |
| 73 | TLK1 | 0.86367712 |
| 74 | MAP2K2 | 0.85882243 |
| 75 | TAOK2 | 0.85372564 |
| 76 | MAP3K4 | 0.85100032 |
| 77 | NLK | 0.84668118 |
| 78 | NME1 | 0.84527544 |
| 79 | BMPR2 | 0.84434010 |
| 80 | PIM2 | 0.82567130 |
| 81 | MAP3K13 | 0.82401447 |
| 82 | EIF2AK3 | 0.81079809 |
| 83 | MAPK11 | 0.80477574 |
| 84 | IKBKB | 0.77698966 |
| 85 | BCR | 0.77016931 |
| 86 | LYN | 0.75841159 |
| 87 | MAP3K12 | 0.73924599 |
| 88 | PRKD2 | 0.73871743 |
| 89 | MAP3K5 | 0.73304990 |
| 90 | ITK | 0.71686749 |
| 91 | RPS6KA4 | 0.70940191 |
| 92 | YES1 | 0.70140768 |
| 93 | PTK2B | 0.69932228 |
| 94 | CLK1 | 0.69829177 |
| 95 | ERN1 | 0.69150586 |
| 96 | MARK3 | 0.68587465 |
| 97 | EPHA3 | 0.68439649 |
| 98 | MATK | 0.67511402 |
| 99 | CAMKK2 | 0.66186636 |
| 100 | LCK | 0.65921974 |
| 101 | DAPK2 | 0.64901393 |
| 102 | GRK5 | 0.64176498 |
| 103 | EIF2AK2 | 0.63618444 |
| 104 | RAF1 | 0.62106914 |
| 105 | CAMK1D | 0.61832154 |
| 106 | JAK1 | 0.61723109 |
| 107 | MAPK12 | 0.61603902 |
| 108 | MAP2K7 | 0.61331080 |
| 109 | VRK1 | 0.58724963 |
| 110 | EIF2AK1 | 0.58613940 |
| 111 | MAPK7 | 0.56557827 |
| 112 | SIK1 | 0.56199488 |
| 113 | CCNB1 | 0.55174181 |
| 114 | RPS6KC1 | 0.54923858 |
| 115 | RPS6KL1 | 0.54923858 |
| 116 | MAPKAPK5 | 0.54533013 |
| 117 | GRK1 | 0.54357463 |
| 118 | CSK | 0.53587190 |
| 119 | RPS6KA6 | 0.53361943 |
| 120 | PKN2 | 0.53231618 |
| 121 | CAMK1 | 0.52946224 |
| 122 | RPS6KA5 | 0.52250999 |
| 123 | ADRBK1 | 0.50281760 |
| 124 | BMPR1B | 0.49713255 |
| 125 | MAP3K7 | 0.49684672 |
| 126 | WNK3 | 0.49117907 |
| 127 | ABL1 | 0.49015910 |
| 128 | PKN1 | 0.48658082 |
| 129 | JAK2 | 0.47388859 |
| 130 | PRKAA2 | 0.44766078 |
| 131 | MAP2K6 | 0.43816391 |
| 132 | HIPK2 | 0.43776639 |
| 133 | OXSR1 | 0.43339050 |
| 134 | ABL2 | 0.42759273 |
| 135 | CAMKK1 | 0.42608516 |
| 136 | TNK2 | 0.41246817 |
| 137 | MAP3K1 | 0.41192900 |
| 138 | PDK2 | 0.40919588 |
| 139 | PRKCE | 0.40639636 |
| 140 | ARAF | 0.39547587 |
| 141 | IGF1R | 0.38949978 |
| 142 | CHUK | 0.38479342 |
| 143 | KDR | 0.38051596 |
| 144 | HCK | 0.37987643 |
| 145 | MOS | 0.37946283 |
| 146 | TGFBR1 | 0.37574895 |
| 147 | PASK | 0.37118398 |
| 148 | PTK6 | 0.36813779 |
| 149 | CDK8 | 0.36427197 |
| 150 | MAPK4 | 0.34920347 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.35259433 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.97286261 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.86260610 |
| 4 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.65886708 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.63181294 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.51245287 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.48746616 |
| 8 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.47480105 |
| 9 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.47167580 |
| 10 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.46908622 |
| 11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.31938049 |
| 12 | Proteasome_Homo sapiens_hsa03050 | 2.15128655 |
| 13 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.13777082 |
| 14 | Sulfur relay system_Homo sapiens_hsa04122 | 1.97195982 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.95070652 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.78298650 |
| 17 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.76483555 |
| 18 | Protein export_Homo sapiens_hsa03060 | 1.75779609 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.73136317 |
| 20 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.68611751 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.61665565 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.58575042 |
| 23 | Phototransduction_Homo sapiens_hsa04744 | 1.55378130 |
| 24 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.53285359 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.52335094 |
| 26 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.48446304 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.47269389 |
| 28 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.46573185 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.44720873 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.44067107 |
| 31 | * Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.43917564 |
| 32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.43074089 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.42928178 |
| 34 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.42905081 |
| 35 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.41486285 |
| 36 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.40852660 |
| 37 | Parkinsons disease_Homo sapiens_hsa05012 | 1.36165469 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.34000622 |
| 39 | Galactose metabolism_Homo sapiens_hsa00052 | 1.33696299 |
| 40 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.33577958 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.31842014 |
| 42 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.27377971 |
| 43 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.21787249 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.19716643 |
| 45 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.19499818 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.19476028 |
| 47 | Alzheimers disease_Homo sapiens_hsa05010 | 1.15331605 |
| 48 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.11687536 |
| 49 | Pertussis_Homo sapiens_hsa05133 | 1.09852170 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.08625418 |
| 51 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.08607271 |
| 52 | Base excision repair_Homo sapiens_hsa03410 | 1.08454756 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 1.06668885 |
| 54 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.06124955 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.05200875 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.04639971 |
| 57 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.03966454 |
| 58 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.01313797 |
| 59 | Ribosome_Homo sapiens_hsa03010 | 0.94537036 |
| 60 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.93119194 |
| 61 | Insulin secretion_Homo sapiens_hsa04911 | 0.90951910 |
| 62 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89634218 |
| 63 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.89054597 |
| 64 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.87516630 |
| 65 | Legionellosis_Homo sapiens_hsa05134 | 0.85857791 |
| 66 | Shigellosis_Homo sapiens_hsa05131 | 0.85604830 |
| 67 | Influenza A_Homo sapiens_hsa05164 | 0.84785924 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.83741616 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.83672639 |
| 70 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.83478479 |
| 71 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.80173861 |
| 72 | Allograft rejection_Homo sapiens_hsa05330 | 0.79876529 |
| 73 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.75858728 |
| 74 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.75624618 |
| 75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.72196758 |
| 76 | Phagosome_Homo sapiens_hsa04145 | 0.71996062 |
| 77 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.71942418 |
| 78 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.71828179 |
| 79 | Apoptosis_Homo sapiens_hsa04210 | 0.71794732 |
| 80 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.71414300 |
| 81 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70632498 |
| 82 | Circadian rhythm_Homo sapiens_hsa04710 | 0.70627824 |
| 83 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.70442247 |
| 84 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.69217355 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.68444006 |
| 86 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.68364170 |
| 87 | Tuberculosis_Homo sapiens_hsa05152 | 0.67440718 |
| 88 | Huntingtons disease_Homo sapiens_hsa05016 | 0.66507111 |
| 89 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.65168660 |
| 90 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.64743182 |
| 91 | Platelet activation_Homo sapiens_hsa04611 | 0.62722441 |
| 92 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61968557 |
| 93 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.61859379 |
| 94 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.60883256 |
| 95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60241985 |
| 96 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.60102282 |
| 97 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.59559451 |
| 98 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.59029950 |
| 99 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.58119467 |
| 100 | Malaria_Homo sapiens_hsa05144 | 0.57726388 |
| 101 | Olfactory transduction_Homo sapiens_hsa04740 | 0.57396604 |
| 102 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56268188 |
| 103 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.55985330 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55702934 |
| 105 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.55130379 |
| 106 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.54983030 |
| 107 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.54487294 |
| 108 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54198212 |
| 109 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.52396407 |
| 110 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50112558 |
| 111 | Hepatitis C_Homo sapiens_hsa05160 | 0.49689024 |
| 112 | Homologous recombination_Homo sapiens_hsa03440 | 0.49652095 |
| 113 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49623973 |
| 114 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.46734688 |
| 115 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.46424739 |
| 116 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.46390111 |
| 117 | Salmonella infection_Homo sapiens_hsa05132 | 0.45607708 |
| 118 | Peroxisome_Homo sapiens_hsa04146 | 0.45317700 |
| 119 | * Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.45297763 |
| 120 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44920377 |
| 121 | RNA degradation_Homo sapiens_hsa03018 | 0.44583577 |
| 122 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.44371620 |
| 123 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44333411 |
| 124 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.43808515 |
| 125 | * Purine metabolism_Homo sapiens_hsa00230 | 0.43649699 |
| 126 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43334640 |
| 127 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.42803873 |
| 128 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.42579753 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42320590 |
| 130 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.41990479 |
| 131 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.41849199 |
| 132 | * RNA polymerase_Homo sapiens_hsa03020 | 0.41837507 |
| 133 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.40102333 |
| 134 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.39255710 |
| 135 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.39085310 |
| 136 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.38655588 |
| 137 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.36358384 |
| 138 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.30023250 |
| 139 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.29623223 |
| 140 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.29387211 |
| 141 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.27913216 |
| 142 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.27643339 |

